Thursday 22 April 2021
Home      All news      Contact us      RSS      India
business-standard - 2 month ago

Covaxin shows 81% efficacy in phase-3 trials, says Bharat Biotech

Firm is gearing up to produce 40 million doses a month. Two Bio-safety Level-3 facilities (which can deal with deadly and contagious viruses) have been set up, third is on the way


Latest News
Hashtags:   

Covaxin

 | 

shows

 | 

efficacy

 | 

phase

 | 

trials

 | 

Bharat

 | 

Biotech

 | 

Sources